Testing two injected medicines together for advanced cancers

This trial is testing a combination of two experimental injectable medicines called OH2 and BS006 for people with advanced solid tumors that have either not responded to standard treatment or have come back after treatment. The medicines are injected directly into the tumor itself, rather than given by mouth or into the vein. Researchers want to see if this approach is safe and whether it helps shrink or control the cancer.

Many people with advanced cancers have limited treatment options after standard therapies stop working or fail. This medication combination represents a new approach—injecting medicines directly into the tumor—that researchers hope might offer benefit to patients who have run out of other choices.